Alzheimer’s Patients Would Not Qualify For The Controversial Drug Trial
The final authorization for a drug named Aduhelm has now become a great controversy. A recent study now adds up to it. It found out that most of the patients who took part in the clinical trial that resulted in its green signal could not have been qualified for it. The US Food and Drug…